Sign in | Register
Home | My Space | Post
Topic: Other Market Topics - Follow Topic
Post your View/Query
Latest | Rated | Top Boarders
(180 replies) 8 hrs ago
Tracked by : 1 boarders
  BEST ADVICE   50 followers
(132 replies) 23 days ago
Yes, after a certain percentage there are many extremely rich farmers. also, those farmers should be taxed who instead of growing crops, grow (construct or give the land for cons.)...
  ajay7varma   3 followers
(85 replies) 16 days ago
For last 35 years the public sectorbanks funds were distributedon the direction of political bosses on papers called project report knowing very well that assumptions on project report wiil never ha...
  malimali   1 followers
(57 replies) 13 days ago
It has done what should have been done in last 30 years...!! happy india.....
  sagi1983   1 followers
(55 replies) 13 days ago
Before buying better take some profits and enter in such a manner to invest to cover safer average cost price....
  Mountain Light   604 followers

Moneycontrol Sentifi Top themes and market attention on

(52 replies) 9 days ago
  cadheerajmehta   0 followers
(48 replies) 15 days ago
Excellent vision and exection of plans....
  pprao   1 followers
(48 replies) 23 days ago
This is time to accumulate. not yet time to sell. let sensex reach 31000....
Tracked by : 1 boarders
  Guest   713 followers
(42 replies) 8 days ago
  corpanalyst   38 followers
(31 replies) 6 days ago
  ememkay49   1 followers
1 | 2 | 3   Next »
  • Name*

  • Email*

  • Contact No.*

  • City

Interested in

  • Both

Confused? use our Compare Brokers feature.

Thank you for registering.

Respective broker representative will reach you shortly.

Indian pharma stocks have de-rated over 10% over the last one year. Is this a good time to relook at pharma stocks ? 1 comments
Stock Boarder Message
Active Topics
Just Posted | index | SpiceJet | Divis Labs | MMTC Ltd
Explore all topics
Boarder of the Day
amateurinvestor (26412 messages | 2207 followers)
Moneycontrol Home
Font Size: S M L
Customer Support
© 2017 a Web18 Venture